These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9570709)

  • 1. Potential therapeutic approaches for the treatment of vaso-occlusion in sickle cell disease.
    Hillery CA
    Curr Opin Hematol; 1998 Mar; 5(2):151-5. PubMed ID: 9570709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell vaso-occlusion.
    Chiang EY; Frenette PS
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):771-84, v. PubMed ID: 16214643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomechanics and biorheology of red blood cells in sickle cell anemia.
    Li X; Dao M; Lykotrafitis G; Karniadakis GE
    J Biomech; 2017 Jan; 50():34-41. PubMed ID: 27876368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium.
    Elion JE; Brun M; Odièvre MH; Lapouméroulie CL; Krishnamoorthy R
    Hematol J; 2004; 5 Suppl 3():S195-8. PubMed ID: 15190308
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.
    Conran N; Franco-Penteado CF; Costa FF
    Hemoglobin; 2009; 33(1):1-16. PubMed ID: 19205968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia.
    Smolinski PA; Offermann MK; Eckman JR; Wick TM
    Blood; 1995 May; 85(10):2945-50. PubMed ID: 7537985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte adhesion in sickle cell disease.
    Parise LV; Telen MJ
    Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell vaso-occlusion: The dialectic between red cells and white cells.
    Conran N; Embury SH
    Exp Biol Med (Maywood); 2021 Jun; 246(12):1458-1472. PubMed ID: 33794696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo.
    McMahon TJ; Shan S; Riccio DA; Batchvarova M; Zhu H; Telen MJ; Zennadi R
    Blood Adv; 2019 Sep; 3(17):2586-2597. PubMed ID: 31484636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell vaso-occlusion.
    Fabry ME; Kaul DK
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):375-98. PubMed ID: 1864816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute complications in sickle cell disease].
    Habibi A; Bachir D; Godeau B
    Rev Prat; 2004 Sep; 54(14):1548-56. PubMed ID: 15558964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion.
    Setty BN; Chen D; O'Neal P; Littrell JB; Grossman MH; Stuart MJ
    J Lab Clin Med; 1998 Apr; 131(4):344-53. PubMed ID: 9579388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease.
    Barabino GA; McIntire LV; Eskin SG; Sears DA; Udden M
    Prog Clin Biol Res; 1987; 240():113-27. PubMed ID: 3615482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
    Connes P; Machado R; Hue O; Reid H
    Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell vaso-occlusion: multistep and multicellular paradigm.
    Frenette PS
    Curr Opin Hematol; 2002 Mar; 9(2):101-6. PubMed ID: 11844991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology of vascular obstruction in the sickle syndromes.
    Kaul DK; Fabry ME; Nagel RL
    Blood Rev; 1996 Mar; 10(1):29-44. PubMed ID: 8861277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological-based approaches to treatment of sickle cell disease.
    Steinberg MH; Brugnara C
    Annu Rev Med; 2003; 54():89-112. PubMed ID: 12359829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies.
    Okoli K; Irani F; Horvath W
    Med Hypotheses; 2009 May; 72(5):578-80. PubMed ID: 19138828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology and treatment of sickle-cell disease].
    van Beers EJ; Peters M; Biemond BJ
    Ned Tijdschr Geneeskd; 2005 May; 149(21):1144-9. PubMed ID: 15940917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.